Isaac Haq

Isaac Haq is an experienced professional in the healthcare and investment sectors, currently serving as a Board Member and Portfolio Management Lead at Biodextris since 2024, while also chairing the Audit, HR, and Compensation committees. Since 2018, Isaac has been part of ArchiMed's Investment Team, focusing on healthcare impact with a previous role as Sector Lead for Life Science Tools & Biologics Services. Other notable positions include Board Director at Title21 Health Solutions, Head of Strategy & Corporate Development at Pluristyx, and Board Observer at multiple companies including Polyplus-transfection and CLEAN BIOLOGICS. Isaac's earlier experience includes roles at Motive Partners as an Analyst, Biotechspert as a Business Development Analyst, and Polygeia as a Researcher. Educational background features degrees from the University of Cambridge, Lancaster University, and The London School of Economics and Political Science.